Michele Morrell is an experienced professional in the pharmaceutical industry, specializing in rare diseases. Michele has held various leadership positions in companies such as Recordati Rare Diseases, Takeda, Shire, Crealta Pharmaceuticals, Savient Pharmaceuticals, and Roche/Genentech. Michele has a Master of Business Administration from the University of Dayton and a Bachelor of Science in Business Administration from Miami University.
December, 2020 - present